# MET-RADS-P (whole-body MRI in advanced prostate cancer)

Source: https://onco.cc/terms/met-rads-p/  
OnCo record `met-rads-p` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

MET-RADS-P is a standard way to perform and report whole-body MRI in advanced prostate cancer, so that spread to the bones and elsewhere is described the same way from scan to scan.

## Summary

Whole-body MRI and PET/CT detect metastases in advanced cancers more accurately than CT and bone scans, but whole-body MRI varies in availability and quality. An international panel (Padhani and colleagues, European Urology 2017) wrote the METastasis Reporting and Data System for Prostate Cancer: minimum acquisition protocol, quality standards and interpretation and reporting rules for all forms of advanced prostate cancer. The authors state it needs validation in trials of established and new treatments.

## Fields

- Kind: Term
- Last checked: 2026-11-04
- Also known as: MET-RADS-P; METastasis Reporting and Data System for Prostate Cancer

## Sources

- Padhani et al., METastasis Reporting and Data System for Prostate Cancer (Eur Urol 2017): https://doi.org/10.1016/j.eururo.2016.05.033

## Connected records

- terms: [MY-RADS (whole-body MRI in myeloma)](https://onco.cc/terms/my-rads/), [ONCO-RADS (whole-body MRI screening in people at high risk)](https://onco.cc/terms/onco-rads/), [PCWG3 (Prostate Cancer Clinical Trials Working Group 3)](https://onco.cc/terms/pcwg3/), [PSMA-RADS (PSMA PET reporting system)](https://onco.cc/terms/psma-rads/)
- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Whole-body MRI](https://onco.cc/technologies/whole-body-mri/)

---
JSON: https://onco.cc/api/v1/entities/met-rads-p.json